SEC Form 4 · accession 0001185185-15-002805
U.S. Stem Cell, Inc. · USRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel S Ahn
Director
Period of report
Nov 3, 2015
Accepted (ET)
Nov 6, 2015 · 4:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388319
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 3, 2015 | P$0 | 2,940 | — | A | 39,675 | D | |
| Common StockF2 | Nov 4, 2015 | P$0 | 295 | — | A | 39,970 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$0.0014 - $0.002 (price at pre-split level; number of shares calculated post-split)
- F2$4.65 - $4.99 (post-split price)